News Coverage
The Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world for more than a decade. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.
This week: 70 months for a Pennsylvania man who trafficked counterfeit medicines, two fentanyl pill operations shut down, counterfeit pill seizures and warnings and a couple of #covidscams.
ADAP Advocacy Association CEO Brandon M. Macsata wrote this editorial, which appeared on the AIDS Drug Assistance Program’s website on April 1, 2021.
The Association first warned constituents that counterfeit Symtuza had been distributed to three U.S. pharmacies in December 2020, when Janssen issued an alert.
This week: The government undertakes scheduling fentanyl analogues, another silicone injection case, a huge counterfeit pill trafficking bust in Quebec, and many, many more fentanyl pills.
Learn why permanently scheduling fentanyl-related substances and analogues on Schedule I of the Controlled Substances Act is an important policy tool in the fight against fentanyl-laced counterfeit medicines.
PSM wanted to shine a spotlight on member organization Rx Outreach. Not only does this organization provide affordable medications for people in need, but Rx Outreach also runs a program called Healthy Reentry to fill the medication gap to help ex-offenders as they transition back into society…
This week: A federal jury indicts a man for smuggling and selling fraudulent COVID-19 treatments, a woman pleads guilty for a silicone injection death in Missouri, police seize nine million fake clonazepam tablets in Europe, and news about counterfeit pills in ten U.S. states.
This week: A new contaminant in hand sanitizers, mystery medicated eye patches, sentencing for Ukrainian counterfeiters and counterfeit pill updates.
On December 17, 2020, FDA issued a press release that warned consumers to avoid certain products found on Amazon, eBay and other retailers due to hidden and potentially dangerous drug ingredients. It also encouraged online marketplaces to ensure these products are not sold on their platforms.
On December 17, 2020, FDA issued a press release that warned consumers to avoid certain products found on Amazon, eBay and other retailers due to hidden and potentially dangerous drug ingredients. It also encouraged online marketplaces to ensure these products are not sold on their platforms.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using these drug products.